SCHEMBL1991544

SCHEMBL1991544

[2H]C([2H])([2H])c1ccc(OCc2ccccc2)c([C@H](CC(=O)N(C(C)C)C(C)C)c2ccccc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.40
HTT P42858 3/20 0.40
NPSR1 Q6W5P4 3/20 0.40
GAA P10253 2/20 0.40
ACP1 P24666 1/20 0.39
PTPN12 Q05209 1/20 0.39
PTPN13 Q12923 1/20 0.39
SSU72 Q9NP77 1/20 0.39
LMNA P02545 2/20 0.38
ALOX5 P09917 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
SLC6A9 P48067 1/20 0.37
SLC6A5 Q9Y345 1/20 0.37
PTGER1 P34995 1/20 0.37
PTGER4 P35408 1/20 0.37
PTGER3 P43115 1/20 0.37
PTGER2 P43116 1/20 0.37
PDE4A P27815 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13257883 0.93 KMT2A (0.47) KMT2AHTTNPSR1GAALMNA
SCHEMBL12986736 0.93 KMT2A (0.47) KMT2AHTTNPSR1GAALMNA
SCHEMBL1994388 0.90 KMT2A (0.39) KMT2AHTTNPSR1GAAACP1
SCHEMBL1995519 0.88 KMT2A (0.45) KMT2AGAAACP1PTPN12PTPN13
SCHEMBL2167293 0.85 LMNA (0.47) KMT2ANPSR1LMNAALDH1A1MEN1
SCHEMBL2167132 0.85 LMNA (0.47) KMT2ANPSR1LMNAALDH1A1MEN1
SCHEMBL14830823 0.85 LMNA (0.47) KMT2ANPSR1LMNAALDH1A1MEN1
SCHEMBL1990967 0.85 ACP1 (0.42) KMT2AGAAACP1PTPN12PTPN13
SCHEMBL1991102 0.84 KMT2A (0.43) KMT2AHTTNPSR1GAAACP1
SCHEMBL1995601 0.84 CHRM2 (0.39) ACP1PTPN12PTPN13SSU72LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152227-A1 DEUTERIUM LABELLED DERIVATIVES OF 3-(2-HYDROXY-5-METHYPHENYL)-N,N-DIISOPROPYL-3-PHENYLPROPYLAMINE AND METHODS OF USE THEREOF CONCERT PHARMACEUTICALS INC. (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152227-A1 DEUTERIUM LABELLED DERIVATIVES OF 3-(2-HYDROXY-5-METHYPHENYL)-N,N-DIISOPROPYL-3-PHENYLPROPYLAMINE AND METHODS OF USE THEREOF ADRB3, CHRM3, QDPR KMT2A 2758/4885HTT 154/4885NPSR1 99/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.